Vaxcyte (PCVX) Non-cash Items (2020 - 2023)

Vaxcyte (PCVX) has 4 years of Non-cash Items data on file, last reported at $4.6 million in Q4 2023.

• Non-cash Items for Q4 2023 came in at $4.6 million, down 56.97% year-over-year; the trailing twelve-month figure through Dec 2023 was $4.6 million (down 56.97% YoY), and the FY2023 annual result was $4.6 million, down 56.97% from the prior year.
• Non-cash Items rose to $4.6 million in Q4 2023 per PCVX's latest filing, from $4.3 million in the prior quarter.
• Over five years, Non-cash Items peaked at $229.0 million in Q3 2020 and troughed at $1.9 million in Q4 2020.
• A 4-year average of $45.6 million and a median of $4.6 million in 2023 frame the typical range for Non-cash Items.
• The sharpest annual moves came in 2022 and 2023: Non-cash Items sank 96.48% in 2022, then soared 762.71% in 2023.
• A 4-year view of Non-cash Items shows it stood at $1.9 million in 2020, then surged by 35.88% to $2.6 million in 2021, then surged by 313.55% to $10.8 million in 2022, then sank by 56.97% to $4.6 million in 2023.
• Business Quant data shows PCVX's Non-cash Items at $4.6 million in Q4 2023, $4.3 million in Q3 2023, and $3.8 million in Q2 2023.